ARCHIVES

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

GYN Group: Open Surgery Would Cost More Lives Than Morcellation

July 25, 2014

DRCCA Board Fails To Agree on New Guidelines For Cancer Control Core Grants, Will Try Again

June 25, 1981

Cooperative Groups Fight Back: Members Seek Move To Multidisciplinary Approach, More Funds

May 30, 1975

Grants & Contracts: NCI Workshop Informs Historically Black Institutions About Funding Process

October 10, 1997

Boyd’s Rebuttal to DePinho’s Letter to the AAUP

May 30, 2014

Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program.

May 21, 2004